Breast Cancer Diagnostics Market
Breast Cancer Diagnostics Market Analysis by Test Type (CA Tests, BRCA Test, ER & PR Test, CEA Test, KRAS Mutation Test, HER 2 Test, PSA Test, EGFR Mutation Test, Immunohistochemistry for Breast Cancer), by End-User & Region - Global Forecast 2022-2032
Analysis of Breast Cancer Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Global Breast Cancer Diagnostics Market Outlook (2022-2032)
The global breast cancer diagnostics market is likely to acquire a market value of US$ 4 Bn in 2022 and is expected to register a CAGR of 7% by accumulating a market value of US$ 7.9 Bn in the forecast period 2022-2032.
|
Market Size Value in 2022 |
US$ 4 Bn |
|
Project Market Forecast Value in 2032 |
US$ 7.9 Bn |
|
Global Growth Rate (2022-2032) |
7% |
|
Market Share of North America |
45% |
|
Key Companies Profiled |
|
Increasing prevalence of breast cancer, reoccurrence of the same and availability of different test is positively influencing the demand for breast cancer diagnostics. Moreover, growing inclination towards early detection of breast cancer diagnosis is driving the demand for breast cancer diagnostics.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Demand Analysis of Breast Cancer Diagnostics from 2017 to 2021 Vs Market Projections for 2022 to 2032
As per Fact.MR’s report, from 2017 to 2021, the global breast cancer diagnostics domain experienced an uptick at around 6% CAGR. Rising prevalence of malignant genes amongst women across generations and fear of passing on the same gene across families led to an increase in the service.
In 2021, WHO stated that, globally, breast cancer is the most common type of cancer, with as much as more than 2.3 Mn new cases being recorded. This increasing instance of breast cancer is largely shaping demand for early breast cancer diagnosis. Rising awareness about breast cancer via various government initiatives and various cancer organizations is boosting market growth.
Screening procedures temporarily dwindled during the worst of the COVID-19 pandemic. As healthcare providers raced to accommodate the exponentially rising caseloads, other diagnostic procedures were put on hold. However, as the incidence receded, prospects rebounded. From 2022 to 2032, breast cancer diagnostics are expected to surpass US$ 7.9 Bn by registering a CAGR of 7% in the assessment period.
Early Detection Bolstering Demand for Breast Cancer Diagnostics?
The number of breast cancer cases across the globe is rising rapidly and has become the most common type of cancer in 2021. Early detection of breast cancer tumours is one of the major challenges in diagnosis and treatment, as in most cases, they are detected after they have grown to an advanced stage.
Demand for early detection of breast cancer is seeing a major rise as people are seeking more efficient diagnostic solutions to deal with the disease effectively. Apart from other tests to detect breast cancer, imaging and screening have also seen substantial rise in popularity. Screening for breast cancer is deemed effective, but some methods are still being debated whether they are safe and accurate for prolonged use.
Breast cancer diagnostic PCR tests, biopsy for breast cancer diagnostics, and application of microarray in breast cancer diagnostics are some of the trends that are expected to be witnessed over the decade.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Different Testing Method Creating Lucrative Opportunities for Breast Cancer Diagnostics?
As research on the detection of breast cancer increases, new and innovative diagnostic methods are being adopted and applied. Most of these methods are not used extensively, but as research is backing their credibility, these methods are expected to become mainstream over the years.
- Diagnostic Imaging for Breast Cancer
- Biopsy Procedure for Breast Cancer Diagnostics
- Genomic Tests for Breast Cancer Diagnostics
- Blood Tests for Breast Cancer Diagnostics
- Next-generation Sequencing for Breast Cancer Diagnostics
- Microarrays in breast cancer diagnostics
Imaging is the most prominent and widely used among these. Demand for genomic tests in breast cancer diagnostics, demand for next-generation sequencing in breast cancer diagnostics, and demand for blood tests in breast cancer diagnostics are relatively low in comparison to imaging due to lack of research to back their credibility, accuracy, and in some cases, even affordability.
Breast biopsy for breast cancer diagnostics is anticipated to see a steady rise in popularity over the decade.
Country-wise Analysis
Well-Established Diagnostics Centres Creating Lucrative Opportunities in North America?
Demand for breast cancer diagnostics in the U.S. is anticipated to increase at a high CAGR owing to rising cases across the nation. Well-established diagnostic infrastructure, technological advancements, increasing healthcare expenditure, and rising awareness about breast cancer are some of the prime factors that are shaping market growth in the country.
Thus, North America is anticipated to account for more than 45% of global breast cancer diagnostics market share in the forecast period 2022-2032.
Affordability Driving Demand for Breast Cancer Diagnostics across Asia Pacific?
Demand in the APAC region is expected to be driven by nations such as China and India, where instances of breast cancer are increasing. Demand for breast cancer diagnostics at independent diagnostic laboratories in the APAC region is expected to see an increase as breast cancer diagnosis instruments become more affordable.
Moreover, the number of women diagnosed with breast cancer has been increasing in India, and this is common across rural as well as urban areas. Breast cancer accounts for nearly 14% of all cancers found in Indian women. In addition, rising instances of cancer is driving demand for early breast cancer diagnostics in the nation. Development of affordable and cost-effective diagnostic solutions is a major factor influencing demand in India. Thus, Asia Pacific is expected to account for more than 40% market share for breast cancer diagnostics market growth through 2032.
Category-Wise Insights
Biopsy Procedure Surging Demand Treatment in Hospital associated Labs?
Rising hospitalization of patients, increasing instances of breast cancer, and rise in demand for biopsy procedure in breast cancer diagnostics are some of the prime factors driving the hospital-associated labs segment.
Thus, adoption of breast cancer diagnostics at hospital-associated labs is high and is expected to account for nearly 50% revenue share of the global market in 2032.
Are Patients Favouring CEA Tests Due to its Accuracy?
As research to find better diagnostic solutions increases, so will demand for breast cancer diagnostics at cancer research institutes. Innovative and early diagnostics solutions for breast cancer are constantly being researched on and the trend is expected to be prevalent through the decade.
Demand for CEA tests for breast cancer is anticipated to witness the highest CAGR. This is due to the test’s capacity to check the probability of reoccurrence of cancer cells. Thus, inclination towards CEA test has increased in recent years. Due to the reasons mentioned above, CEA test are expected to hold more than 45% market share for Breast Cancer Diagnostics.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Prime providers of breast cancer diagnostics are striving to come up with diagnostic solutions that offer early detection of breast cancer. Key market players are also investing in the research & development of diagnostic solutions that are fast, accurate, and cost-efficient.
- Vice President of India, Shri M. Venkaiah Naidu, in September 2021, launched the first-of-its-kind breast cancer helpline, set up by the Ushalakshmi Breast Cancer Foundation. This is a new step for the nation to spread awareness about breast cancer.
- Elizabeth Hurley, actress and model, launched a cancer support center in London in September 2021, ahead of the cancer awareness month. The support centre was named Future Dreams House.
- In October 2021, to increase awareness about breast cancer, WellSpan Health and Capital Blue Cross, in collaboration, launched a mobile mammography motor coach, which is in accordance with their goal to increase screening for breast cancer across five countries.
Key Segments Covered in the Breast Cancer Diagnostics Report
-
By Test Type
- CA Tests for Breast Cancer
- BRCA Test for Breast Cancer
- ER & PR Test for Breast Cancer
- CEA Test for Breast Cancer
- KRAS Mutation Test for Breast Cancer
- HER 2 Test for Breast Cancer
- PSA Test for Breast Cancer
- EGFR Mutation Test for Breast Cancer
- Immunohistochemistry for Breast Cancer
- Others
-
By End User
- Hospital Associated Labs
- Independent Diagnostic Laboratories
- Cancer Research Institutes
- Others
Table of Content
Chapter 1 Global Breast Cancer Diagnostics Market - Executive Summary Chapter 2 Global Breast Cancer Diagnostics Market Overview 2.1 Introduction 2.1.1 Global Breast Cancer Diagnostics Market Taxonomy 2.1.2 Global Breast Cancer Diagnostics Market Definition 2.2 Global Breast Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2017-2032 2.2.1 Global Breast Cancer Diagnostics Market Y-o-Y Growth 2.3 Global Breast Cancer Diagnostics Market Dynamics 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Trends 2.4 Supply Chain 2.5 Epidemiology 2.6 List of Distributors 2.7 Average Pricing Analysis 2.8 Regulations 2.9 Key Participants Market Presence (Intensity Map) By Region Chapter 3 Global Breast Cancer Diagnostics Market Analysis and Forecast By Test Type 3.1 Global Breast Cancer Diagnostics Market Size and Forecast By Test Type, 2017-2032 3.1.1 BRCA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.1.1 Revenue (US$ Mn) Comparison, By Region 3.1.1.2 Market Share Comparison, By Region 3.1.1.3 Y-o-Y growth Comparison, By Region 3.1.2 ER & PR Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.2.1 Revenue (US$ Mn) Comparison, By Region 3.1.2.2 Market Share Comparison, By Region 3.1.2.3 Y-o-Y growth Comparison, By Region 3.1.3 CEA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.3.1 Revenue (US$ Mn) Comparison, By Region 3.1.3.2 Market Share Comparison, By Region 3.1.3.3 Y-o-Y growth Comparison, By Region 3.1.4 KRAS Mutation Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.4.1 Revenue (US$ Mn) Comparison, By Region 3.1.4.2 Market Share Comparison, By Region 3.1.4.3 Y-o-Y growth Comparison, By Region 3.1.5 HER 2 Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.5.1 Revenue (US$ Mn) Comparison, By Region 3.1.5.2 Market Share Comparison, By Region 3.1.5.3 Y-o-Y growth Comparison, By Region 3.1.6 PSA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.6.1 Revenue (US$ Mn) Comparison, By Region 3.1.6.2 Market Share Comparison, By Region 3.1.6.3 Y-o-Y growth Comparison, By Region 3.1.7 CA Test Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.7.1 Revenue (US$ Mn) Comparison, By Region 3.1.7.2 Market Share Comparison, By Region 3.1.7.3 Y-o-Y growth Comparison, By Region 3.1.8 EGFR Mutation Test Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.8.1 Revenue (US$ Mn) Comparison, By Region 3.1.8.2 Market Share Comparison, By Region 3.1.8.3 Y-o-Y growth Comparison, By Region 3.1.9 Immunohistochemistry Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.9.1 Revenue (US$ Mn) Comparison, By Region 3.1.9.2 Market Share Comparison, By Region 3.1.9.3 Y-o-Y growth Comparison, By Region 3.1.10 Others Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 3.1.10.1 Revenue (US$ Mn) Comparison, By Region 3.1.10.2 Market Share Comparison, By Region 3.1.10.3 Y-o-Y growth Comparison, By Region Chapter 4 Global Breast Cancer Diagnostics Market Analysis and Forecast By End User 4.1 Global Breast Cancer Diagnostics Market Size and Forecast By End User, 2017-2032 4.1.1 Hospital Associated Labs Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 4.1.1.1 Revenue (US$ Mn) Comparison, By Region 4.1.1.2 Market Share Comparison, By Region 4.1.1.3 Y-o-Y growth Comparison, By Region 4.1.2 Independent Diagnostic Laboratories Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 4.1.2.1 Revenue (US$ Mn) Comparison, By Region 4.1.2.2 Market Share Comparison, By Region 4.1.2.3 Y-o-Y growth Comparison, By Region 4.1.3 Cancer Research Institutes Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 4.1.3.1 Revenue (US$ Mn) Comparison, By Region 4.1.3.2 Market Share Comparison, By Region 4.1.3.3 Y-o-Y growth Comparison, By Region 4.1.4 Others Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 4.1.4.1 Revenue (US$ Mn) Comparison, By Region 4.1.4.2 Market Share Comparison, By Region 4.1.4.3 Y-o-Y growth Comparison, By Region Chapter 5 Global Breast Cancer Diagnostics Market Analysis and Forecast By Region 5.1 Global Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 5.1.1 North America Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 5.1.1.1 Revenue (US$ Mn) Comparison, By Test Type 5.1.1.2 Revenue (US$ Mn) Comparison, By End User 5.1.2 Latin America Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 5.1.2.1 Revenue (US$ Mn) Comparison, By Test Type 5.1.2.2 Revenue (US$ Mn) Comparison, By End User 5.1.3 Europe Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 5.1.3.1 Revenue (US$ Mn) Comparison, By Test Type 5.1.3.2 Revenue (US$ Mn) Comparison, By End User 5.1.4 Japan Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 5.1.4.1 Revenue (US$ Mn) Comparison, By Test Type 5.1.4.2 Revenue (US$ Mn) Comparison, By End User 5.1.5 APEJ Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 5.1.5.1 Revenue (US$ Mn) Comparison, By Test Type 5.1.5.2 Revenue (US$ Mn) Comparison, By End User 5.1.6 MEA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 5.1.6.1 Revenue (US$ Mn) Comparison, By Test Type 5.1.6.2 Revenue (US$ Mn) Comparison, By End User Chapter 6 North America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032 6.1 US Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 6.1.1 Revenue (US$ Mn) Comparison, By Test Type 6.1.2 Revenue (US$ Mn) Comparison, By End User 6.2 Canada Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 6.2.1 Revenue (US$ Mn) Comparison, By Test Type 6.2.2 Revenue (US$ Mn) Comparison, By End User Chapter 7 Latin America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032 7.1 Brazil Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 7.1.1 Revenue (US$ Mn) Comparison, By Test Type 7.1.2 Revenue (US$ Mn) Comparison, By End User 7.2 Mexico Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 7.2.1 Revenue (US$ Mn) Comparison, By Test Type 7.2.2 Revenue (US$ Mn) Comparison, By End User 7.3 Argentina Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 7.3.1 Revenue (US$ Mn) Comparison, By Test Type 7.3.2 Revenue (US$ Mn) Comparison, By End User Chapter 8 Europe Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032 8.1 Germany Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 8.1.1 Revenue (US$ Mn) Comparison, By Test Type 8.1.2 Revenue (US$ Mn) Comparison, By End User 8.2 UK Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 8.2.1 Revenue (US$ Mn) Comparison, By Test Type 8.2.2 Revenue (US$ Mn) Comparison, By End User 8.3 France Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 8.3.1 Revenue (US$ Mn) Comparison, By Test Type 8.3.2 Revenue (US$ Mn) Comparison, By End User 8.4 Spain Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 8.4.1 Revenue (US$ Mn) Comparison, By Test Type 8.4.2 Revenue (US$ Mn) Comparison, By End User 8.5 Italy Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 8.5.1 Revenue (US$ Mn) Comparison, By Test Type 8.5.2 Revenue (US$ Mn) Comparison, By End User 8.6 Nordic Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 8.6.1 Revenue (US$ Mn) Comparison, By Test Type 8.6.2 Revenue (US$ Mn) Comparison, By End User Chapter 9 Japan Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032 9.1 Japan Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 9.1.1 Revenue (US$ Mn) Comparison, By Test Type 9.1.2 Revenue (US$ Mn) Comparison, By End User Chapter 10 APEJ Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032 116 10.1 China Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 10.1.1 Revenue (US$ Mn) Comparison, By Test Type 10.1.2 Revenue (US$ Mn) Comparison, By End User 10.2 India Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 10.2.1 Revenue (US$ Mn) Comparison, By Test Type 10.2.2 Revenue (US$ Mn) Comparison, By End User 10.3 Malaysia Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 10.3.1 Revenue (US$ Mn) Comparison, By Test Type 10.3.2 Revenue (US$ Mn) Comparison, By End User 10.4 Thailand Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 10.4.1 Revenue (US$ Mn) Comparison, By Test Type 10.4.2 Revenue (US$ Mn) Comparison, By End User 10.5 Singapore Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 10.5.1 Revenue (US$ Mn) Comparison, By Test Type 10.5.2 Revenue (US$ Mn) Comparison, By End User 10.6 Australia Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 10.6.1 Revenue (US$ Mn) Comparison, By Test Type 10.6.2 Revenue (US$ Mn) Comparison, By End User Chapter 11 MEA Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032 11.1 GCC Countries Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 11.1.1 Revenue (US$ Mn) Comparison, By Test Type 11.1.2 Revenue (US$ Mn) Comparison, By End User 11.2 South Africa Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 11.2.1 Revenue (US$ Mn) Comparison, By Test Type 11.2.2 Revenue (US$ Mn) Comparison, By End User 11.3 Nigeria Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 11.3.1 Revenue (US$ Mn) Comparison, By Test Type 11.3.2 Revenue (US$ Mn) Comparison, By End User 11.4 Israel Breast Cancer Diagnostics Market Size and Forecast, 2017-2032 11.4.1 Revenue (US$ Mn) Comparison, By Test Type 11.4.2 Revenue (US$ Mn) Comparison, By End User Chapter 12 Company Profiles 12.1 Abbott Laboratories 12.1.1 Company Overview 12.1.2 Product Overview: 12.1.3 Key Financials: 12.1.4 SWOT Analysis 12.1.5 Key Developments 12.2 Roche Holding AG. 12.2.1 Company Overview 12.2.2 Product Overview: 12.2.3 Key Financials: 12.2.4 Key Developments 12.3 Thermo Fisher Scientific Inc. 12.3.1 Company Overview 12.3.2 Product Overview: 12.3.3 Key Financials: 12.3.4 SWOT Analysis 12.3.5 Key Developments 12.4 Siemens AG 12.4.1 Company Overview 12.4.2 Product Overview: 12.4.3 Key Financials: 12.4.4 SWOT Analysis 12.4.5 Key Developments 12.5 Bio-Rad Laboratories, Inc. 12.5.1 Company Overview 12.5.2 Product Overview: 12.5.3 SWOT Analysis 12.5.4 Key Developments 12.6 Illumina, Inc. 150 12.6.1 Company Overview 12.6.2 Product Overview: 12.6.3 Key Financials: 12.6.4 SWOT Analysis 12.6.5 Key Development 12.7 Biocept, Inc. 12.7.1 Company Overview 12.7.2 Product Overview: 12.7.3 Key Financials 12.7.4 Key Developments 12.8 AstraZeneCA plc 12.8.1 Company Overview 12.8.2 Product Overview: 12.8.3 Key Financials 12.8.4 Key Developments 12.8.5 SWOT Analysis 12.9 Myriad Genetics Inc 12.9.1 Company Overview 12.9.2 Product Overview 12.9.3 Key Financials 12.9.4 SWOT Analysis 12.10 Quest Diagnostics Incorporated 12.10.1 Company Overview 12.10.2 Product Overview 12.10.3 Key Financials 12.10.4 SWOT Analysis Chapter 13 Disclaimer and Contact information
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 1: Global Breast Cancer Diagnostics Market Value (US$ Mn), 2017-2021
TABLE 2: Global Breast Cancer Diagnostics Market Value (US$ Mn), 2022-2032
TABLE 3: Global Breast Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2032 Value (US$ Mn)
TABLE 4: Global BRCA Segment Value (US$ Mn), By Region 2017-2021
TABLE 5: Global BRCA Segment Value (US$ Mn), By Region 2022-2032
TABLE 6: Global BRCA Segment Market Share, By Region 2017-2021
TABLE 7: Global BRCA Segment Market Share, By Region 2022-2032
TABLE 8: Global BRCA Segment Y-o-Y, By Region 2017-2032
TABLE 9: Global ER & PR Segment Value (US$ Mn), By Region 2017-2021
TABLE 10: Global ER & PR Segment Value (US$ Mn), By Region 2022-2032
TABLE 11: Global ER & PR Segment Market Share, By Region 2017-2021
TABLE 12: Global ER & PR Segment Market Share, By Region 2022-2032
TABLE 13: Global ER & PR Segment Y-o-Y, By Region 2017-2032
TABLE 14: Global CEA Segment Value (US$ Mn), By Region 2017-2021
TABLE 15: Global CEA Segment Value (US$ Mn), By Region 2022-2032
TABLE 16: Global CEA Segment Market Share, By Region 2017-2021
TABLE 17: Global CEA Segment Market Share, By Region 2022-2032
TABLE 18: Global CEA Segment Y-o-Y, By Region 2017-2032
TABLE 19: Global KRAS Mutation Segment Value (US$ Mn), By Region 2017-2021
TABLE 20: Global KRAS Mutation Segment Value (US$ Mn), By Region 2022-2032
TABLE 21: Global KRAS Mutation Segment Market Share, By Region 2017-2021
TABLE 22: Global KRAS Mutation Segment Market Share, By Region 2022-2032
TABLE 23: Global KRAS Mutation Segment Y-o-Y, By Region 2017-2032
TABLE 24: Global HER 2 Segment Value (US$ Mn), By Region 2017-2021
TABLE 25: Global HER 2 Segment Value (US$ Mn), By Region 2022-2032
TABLE 26: Global HER 2 Segment Market Share, By Region 2017-2021
TABLE 27: Global HER 2 Segment Market Share, By Region 2022-2032
TABLE 28: Global HER 2 Segment Y-o-Y, By Region 2017-2032
TABLE 29: Global PSA Segment Value (US$ Mn), By Region 2017-2021
TABLE 30: Global PSA Segment Value (US$ Mn), By Region 2022-2032
TABLE 31: Global PSA Segment Market Share, By Region 2017-2021
TABLE 32: Global PSA Segment Market Share, By Region 2022-2032
TABLE 33: Global PSA Segment Y-o-Y, By Region 2017-2032
TABLE 34: Global CA Test Segment Value (US$ Mn), By Region 2017-2021
TABLE 35: Global CA Test Segment Value (US$ Mn), By Region 2022-2032
TABLE 36: Global CA Test Segment Market Share, By Region 2017-2021
TABLE 37: Global CA Test Segment Market Share, By Region 2022-2032
TABLE 38: Global CA Test Segment Y-o-Y, By Region 2017-2032
TABLE 39: Global EGFR Mutation Test Segment Value (US$ Mn), By Region 2017-2021
TABLE 40: Global EGFR Mutation Test Segment Value (US$ Mn), By Region 2022-2032
TABLE 41: Global EGFR Mutation Test Segment Market Share, By Region 2017-2021
TABLE 42: Global EGFR Mutation Test Segment Market Share, By Region 2022-2032
TABLE 43: Global EGFR Mutation Test Segment Y-o-Y, By Region 2017-2032
TABLE 44: Global Immunohistochemistry Segment Value (US$ Mn), By Region 2017-2021
TABLE 45: Global Immunohistochemistry Segment Value (US$ Mn), By Region 2022-2032MEA
TABLE 46: Global Immunohistochemistry Segment Market Share, By Region 2017-2021
TABLE 47: Global Immunohistochemistry Segment Market Share, By Region 2022-2032
TABLE 48: Global Immunohistochemistry Segment Y-o-Y, By Region 2017-2032
TABLE 49: Global Others Segment Value (US$ Mn), By Region 2017-2021
TABLE 50: Global Others Segment Value (US$ Mn), By Region 2022-2032
TABLE 51: Global Others Segment Market Share, By Region 2017-2021
TABLE 52: Global Others Segment Market Share, By Region 2022-2032
TABLE 53: Global Others Segment Y-o-Y, By Region 2017-2032
TABLE 54: Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2017-2021
TABLE 55: Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2022-2032
TABLE 56: Global Hospital Associated Labs Segment Market Share, By Region 2017-2021
TABLE 57: Global Hospital Associated Labs Segment Market Share, By Region 2022-2032
TABLE 58: Global Hospital Associated Labs Segment Y-o-Y, By Region 2017-2032
TABLE 59: Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2017-2021
TABLE 60: Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2022-2032
TABLE 61: Global Independent Diagnostic Laboratories Segment Market Share, By Region 2017-2021
TABLE 62: Global Independent Diagnostic Laboratories Segment Market Share, By Region 2022-2032
TABLE 63: Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2017-2032
TABLE 64: Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2017-2021
TABLE 65: Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2022-2032
TABLE 66: Global Cancer Research Institutes Segment Market Share, By Region 2017-2021
TABLE 67: Global Cancer Research Institutes Segment Market Share, By Region 2022-2032
TABLE 68: Global Cancer Research Institutes Segment Y-o-Y, By Region 2017-2032
TABLE 69: Global Others Segment Value (US$ Mn), By Region 2017-2021
TABLE 70: Global Others Segment Value (US$ Mn), By Region 2022-2032
TABLE 71: Global Others Segment Market Share, By Region 2017-2021
TABLE 72: Global Others Segment Market Share, By Region 2022-2032
TABLE 73: Global Others Segment Y-o-Y, By Region 2017-2032
TABLE 74: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 75: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 76: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 77: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 78: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 79: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 80: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 81: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 82: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 83: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 84: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 85: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 86: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 87: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 88: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 89: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 90: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 91: Source: FactMR, 2021APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 92: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 93: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 94: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 95: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 96: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 97: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 98: US Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 99: US Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 100: US Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 101: US Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 102: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 103: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 104: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 105: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 106: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 107: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 108: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 109: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 110: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 111: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 112: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 113: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 114: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 115: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 116: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 117: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 118: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 119: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 120: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 121: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 122: UK Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 123: UK Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 124: UK Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 125: UK Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 126: France Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 127: France Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 128: France Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 129: France Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 130: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 131: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 132: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 133: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 134: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 135: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 136: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 137: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 138: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 139: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 140: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 141: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 142: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 143: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 144: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 145: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 146: China Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 147: China Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 148: China Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 149: China Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 150: India Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 151: India Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 152: India Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 153: India Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 154: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 155: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 156: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 157: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 158: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 159: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 160: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 161: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 162: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 163: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 164: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 165: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 166: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 167: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 168: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 169: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 170: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 171: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 172: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 173: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 174: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 175: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 176: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 177: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 178: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 179: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 180: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 181: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 182: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
TABLE 183: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 184: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
TABLE 185: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 1: Global Breast Cancer Diagnostics Market Value (US$ Mn), 2017-2021: Global Breast Cancer Value), 2022-2032 Value (US$ Mn)
FIG. 2: Breast Cancer Diagnostics Market Value (US$ Mn) Forecast, 2022-2032
FIG. 3: Global Breast Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2032
FIG. 4: Global BRCA Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 5: Global BRCA Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 6: Global BRCA Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 7: Global ER & PR Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 8: Global ER & PR Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 9: Global ER & PR Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 10: Global CEA Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 11: Global CEA Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 12: Global CEA Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 13: Global KRAS Mutation Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 14: Global KRAS Mutation Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 15: Global KRAS Mutation Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 16: Global HER 2 Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 17: Global HER 2 Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 18: Global HER 2 Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 19: Global PSA Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 20: Global PSA Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 21: Global PSA Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 22: Global CA Test Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 23: Global CA Test Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 24: Global CA Test Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 25: Global EGFR Mutation Test Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 26: Global EGFR Mutation Test Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 27: Global EGFR Mutation Test Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 28: Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 29: Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 30: Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 31: Global Others Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 32: Global Others Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 33: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 34: Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 35: Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 36: Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 37: Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 38: Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 39: Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 40: Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 41: Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 42: Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2017-2032
FIG. 43: Global Others Segment Market Value (US$ Mn) By Region, 2017-2021
FIG. 44: Global Others Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 45: Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 46: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
FIG. 47: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 48: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
FIG. 49: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 50: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
FIG. 51: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 52: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
FIG. 53: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 54: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
FIG. 55: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 56: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
FIG. 57: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 58: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
FIG. 59: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 60: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
FIG. 61: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 62: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
FIG. 63: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 64: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
FIG. 65: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 66: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021
FIG. 67: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 68: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021
FIG. 69: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the breast cancer diagnostics industry worth?
As of 2022, the market for breast cancer diagnostics will reach nearly US$ 4 Bn
At what rate will the breast cancer diagnostics industry grow from 2022-2032?
The breast cancer diagnostics industry is expected to surpass a CAGR of 7% from 2022-2032.
How much is the breast cancer diagnostics market like to be valued by 2032?
The breast cancer diagnostics market is expected to reach nearly US$ 7.9 Bn by 2032
What are the key trends driving breast cancer diagnostics sales?
Availability of multiple tests along with accurate results and technological advancements are the key trends driving breast cancer diagnostics sales.
Who are the prominent breast cancer diagnostics market players?
Bio-Rad Laboratories Inc, Illumina Inc, Biocept Inc, Epigenomics AG, AstraZeneca plc, Myriad Genetics Inc and Quest Diagnostics Incorporated are prominent breast cancer diagnostics market players.
Which type of test is expected to hold the highest share for sales?
CEA test are expected to hold more than 45% market share for Breast Cancer Diagnostics.
Which type of course is expected to hold the highest share for sales?
Hospital based labs are expected to hold more than 50% market share for breast cancer diagnostics market.
How much is the North America breast cancer diagnostics industry worth?
The breast cancer diagnostics industry is expected to possess nearly 45% market share throughout North America.
How much is the Asia Pacific breast cancer diagnostics industry worth?
The breast cancer diagnostics industry is expected to possess nearly 40% market share throughout Asia Pacific.
Breast Cancer Diagnostics Market